Abiomed reported $217.04M in Gross Profit on Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbott ABT:US USD 5.78B 543M
Abiomed ABMD:US USD 217.04M 7.48M
Atricure ATRC:US USD 61.71M 1.81M
Baxter International BAX:US USD 1.15B 310M
Boston Scientific BSX:US USD 2.18B 42M
Cardiovascular Systems CSII:US USD 42.98M 3.25M
Cooper Companies COO:US USD 552.1M 19.6M
Dexcom DXCM:US USD 494.2M 44.7M
Edwards Lifesciences EW:US USD 1.07B 37.7M
Getinge GETIB:SS SEK 3.38B 231M
Hologic HOLX:US USD 522.9M 36.1M
Insulet PODD:US USD 188.3M 2M
Integra Lifesciences IART:US USD 240.94M 13.6M
Johnson & Johnson JNJ:US USD 15.98B 134M
Masimo MASI:US USD 282.5M 24.3M
Medtronic MDT:US USD 5.11B 232M
Merit Medical Systems MMSI:US USD 128.57M 6.49M
Nuvasive NUVA:US USD 214.41M 10.28M
Stryker SYK:US USD 2.8B 41M
Tandem Diabetes Care TNDM:US USD 104.42M 2.48M
Teleflex TFX:US USD 373.96M 14.88M
Terumo 4543:JP JPY 105.36B 3.72B
Zimmer Biomet Holdings Inc ZBH:US USD 1.18B 89.2M